The Tendril Plot-a novel visual summary of the incidence, significance and temporal aspects of adverse events in clinical trials

被引:7
作者
Karpefors, Martin [1 ]
Weatherall, James [2 ]
机构
[1] AstraZeneca R&D, Adv Analyt Ctr, Gothenburg, Sweden
[2] AstraZeneca R&D, Adv Analyt Ctr, Macclesfield, Cheshire, England
关键词
Patient safety; Visualization; Adverse event; Safety assessment; Clinical; Respiratory; ROFLUMILAST;
D O I
10.1093/jamia/ocy016
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Background: In contrast to efficacy, safety hypotheses of clinical trials are not always pre-specified, and therefore, the safety interpretation work of a trial tends to be more exploratory, often reactive, and the analysis more statistically and graphically challenging. Methods: We introduce a new means of visualizing the adverse event data across an entire clinical trial. Results: The approach overcomes some of the current limitations of adverse event analysis and streamlines the way safety data can be explored, interpreted and analyzed. Using a phase II study, we describe and exemplify how the tendril plot effectively summarizes the time-resolved safety profile of two treatment arms in a single plot and how that can provide scientists with a trial safety overview that can support medical decision making. Conclusion: To our knowledge, the tendril plot is the only way to graphically show important treatment differences with preserved temporal information, across an entire clinical trial, in a single view.
引用
收藏
页码:1069 / 1073
页数:5
相关论文
共 10 条
[1]   Graphical approaches to the analysis of safety data from clinical trials [J].
Amit, Ohad ;
Heiberger, Richard M. ;
Lane, Peter W. .
PHARMACEUTICAL STATISTICS, 2008, 7 (01) :20-35
[2]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[3]   Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials [J].
Calverley, Peter M. A. ;
Rabe, Klaus F. ;
Goehring, Udo-Michael ;
Kristiansen, Soren ;
Fabbri, Leonardo M. ;
Martinez, Fernando J. .
LANCET, 2009, 374 (9691) :685-694
[4]   Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team [J].
Crowe, Brenda J. ;
Xia, H. Amy ;
Berlin, Jesse A. ;
Watson, Douglas J. ;
Shi, Hongliang ;
Lin, Stephen L. ;
Kuebler, Juergen ;
Schriver, Robert C. ;
Santanello, Nancy C. ;
Rochester, George ;
Porter, Jane B. ;
Oster, Manfred ;
Mehrotra, Devan V. ;
Li, Zhengqing ;
King, Eileen C. ;
Harpur, Ernest S. ;
Hall, David B. .
CLINICAL TRIALS, 2009, 6 (05) :430-440
[5]  
Karpefors M, TENDRIL R PACKAGE RE
[6]   Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE2SPOND) A Randomized Clinical Trial [J].
Martinez, Fernando J. ;
Rabe, Klaus F. ;
Sethi, Sanjay ;
Pizzichini, Emilio ;
Mclvor, Andrew ;
Anzueto, Antonio ;
Alagappan, Vijay K. T. ;
Siddiqui, Shahid ;
Rekeda, Ludmyla ;
Miller, Christopher J. ;
Zetterstrand, Sofia ;
Reisner, Colin ;
Rennard, Stephen I. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (05) :559-567
[7]  
Pournelle G. H., 1953, Journal of Mammalogy, V34, P133, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO
[8]  
2
[9]  
Stefaner M, 2010, NOTABILIA VISUALIZIN
[10]   Summarizing the incidence of adverse events using volcano plots and time intervals [J].
Zink, Richard C. ;
Wolfinger, Russell D. ;
Mann, Geoffrey .
CLINICAL TRIALS, 2013, 10 (03) :398-406